Goldman Sachs’s Agile Therapeutics AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $12K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $305K | Buy |
|
|||||
|
2021
Q1 | $73K | Buy |
|
|||||
|
2020
Q4 | $50K | Sell |
|
|||||
|
2020
Q3 | $62K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $118K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $34K | Sell |
|
|||||
|
2017
Q4 | $41K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $309K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $405K | Sell |
|
|||||
|
2015
Q1 | $597K | Buy |
|
|||||
|
2014
Q4 | $348K | Sell |
|
|||||
|
2014
Q3 | $612K | Buy |
|
|||||
|
2014
Q2 | $194K | Buy |
|